BENCHMARK RESEARCH TRIAL
This team includes Melissa Reynolds, RN, BSN, CCRC, Executive Vice President of Clinical Operations, who has more than 25 years’ experience in clinical research, including having directed two other research organizations and currently implementing all trial budget and contract management for Benchmark’s multiple locations. As noted by CEO Mark Lacy, “Benchmark is thrilled to add such an industry powerhouse to our ranks that further establishes us as the most prominent platform-based research company in the United States.”Ĭindy joins a truly outstanding leadership team composed of members with immense industry experience.
As well as receiving the Pharma Times Top 100 for contributions to vaccine and infectious disease, Top 50 Influential People in Vaccines, and Top Leader of ICON Clinical Research. She is a distinguished Alumni of the Baylor College of Medicine for international contributions to vaccine and infectious disease. Cindy has extensive Site, Pharma, Biotech, and CRO experience across multiple therapeutic areas including vaccines, infectious diseases, oncology, and more. She is one of the premier world-recognized professionals in the vaccine industry, with over 40 years of diversified clinical experience.
In a bold move, Benchmark Research is very proud to announce the addition of Cynthia Dukes, PA, MT, as Chief Business Officer to Benchmark’s stellar leadership team. Benchmark Research, a leader in the medical research field, clinical vaccine trials and trusted ally in epidemiology, has been taking their firm to another level of success in the industry.
0 kommentar(er)
